Insider Shareholders with Direct Ownership of Cyclacel Pharmaceuticals, Inc. (CYCC)
This section provides a comprehensive overview of the insiders with direct ownership of Cyclacel Pharmaceuticals, Inc. (CYCC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cyclacel Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Wong Sing Ee Doris
Chief Executive Officer |
300,178 | 0 | 1,111,131 $5.73 Million | 1 |
Nov 12, 2025
Added 21.27%
|
|
Kim Choy Yap
> 10% Shareholder |
654,000 | 404,505 | 467,535 $2.41 Million | 8 |
Nov 05, 2025
Added 50.0%
|
|
Khai Loon Kua
> 10% Shareholder |
654,000 | 404,465 | 467,535 $2.41 Million | 8 |
Nov 05, 2025
Added 50.0%
|
|
Yee Lung Ong
> 10% Shareholder |
654,000 | 404,465 | 467,535 $2.41 Million | 5 |
Nov 05, 2025
Added 50.0%
|
|
Diversified Berhad Fitters
> 10% Shareholder |
0 | 419,910 | 279,248 $1.44 Million | 5 |
Oct 21, 2025
Reduced 24.85%
|
|
Cu Seng Kiu
Chief Financial Officer |
200,000 | 0 | 200,000 $1.03 Million | 1 |
Nov 12, 2025
Added 50.0%
|
|
David E. Lazar
> 10% Shareholder |
194,628,820 | 194,635,570 | 155,838 $804,124 | 3 |
Jul 30, 2025
Reduced 4.15%
|
|
David Natan
Director |
100,000 | 0 | 100,000 $516,000 | 1 |
Jan 02, 2025
Added 50.0%
|
|
Spiro George Rombotis
President and CEO |
67,670 | 0 | 68,658 $354,275 | 3 |
Dec 21, 2023
Added 8.12%
|
|
Kenneth M. Ferguson
Director |
48,952 | 0 | 44,952 $231,952 | 2 |
Jun 30, 2023
Added 32.07%
|
|
Karin L Walker
Director |
40,602 | 0 | 40,602 $209,506 | 3 |
Jun 30, 2023
Added 34.32%
|
|
Sam L Barker
Director |
40,415 | 12 | 40,415 $208,541 | 5 |
Jun 30, 2023
Added 34.43%
|
|
Christopher S Henney
Director |
39,415 | 0 | 39,415 $203,381 | 3 |
Jun 30, 2023
Added 35.0%
|
|
Robert J. Spiegel
Director |
39,415 | 0 | 39,415 $203,381 | 3 |
Jun 30, 2023
Added 35.0%
|
|
Paul Mc Barron
Director |
33,086 | 0 | 33,378 $172,230 | 2 |
Dec 21, 2023
Added 5.35%
|
|
Mark Kirschbaum
Chief Medical Officer |
31,200 | 0 | 31,200 $160,992 | 1 |
Jan 31, 2023
Added 50.0%
|
|
Lloyd Sems
Director |
18,196 | 0 | 18,196 $93,891 | 2 |
Jun 14, 2022
Added 46.51%
|
|
Brian Schwartz
Interim Chief Medical Officer |
53,102 | 0 | 15,205 $78,457 | 4 |
Jan 29, 2024
Added 45.12%
|
|
Gregory T. Hradsky
Director |
2,374 | 0 | 2,374 $12,249 | 1 |
Jun 15, 2021
Added 50.0%
|